CCDR: Volume 46–2/3 - Feb/Mar 2020: Public Health Network

CCDR: Volume 46–2/3 - Feb/Mar 2020: Public Health Network The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 2020-02-06 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyPublic healthnetworksknowledge synthesisknowledge translationhealth equitydeterminants of healthevidence-informed practiceevidence-informed decision-making CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health NetworkHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020.html CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health NetworkHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020.html CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health NetworkPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23-eng.pdf CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health NetworkPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23f-fra.pdf Networking—A quintessential public health activityHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-1-networking-public-health.html Networking—A quintessential public health activityHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-1-reseautage-sante-publique.html Networking—A quintessential public health activityPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01f-fra.pdf Networking—A quintessential public health activityPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01-eng.pdf Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public healthHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-2-canada-national-collaboration-centres-public-health.html Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public healthHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-2-centre-collaboration-nationale-sante-publique-canada.html Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public healthPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02-eng.pdf Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public healthPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02f-fra.pdf Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B DiseaseHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-3-naci-bivalent-factor-h-binding-protein-meningococcal-serogroup-b.html Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B DiseaseHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-3-ccni-proteine-liaison-bivalente-facteur-h-meningocoque-serogroupe-b.html Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B DiseasePDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03-eng.pdf Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B DiseasePDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03f-fra.pdf Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-4-infection-prevention-control-lapse-ontario-2018.html Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-4-prevention-infections-manquements-mesures-controle-ontario-2018.html Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04-eng.pdf Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04f-fra.pdf Optimizing communication material to address vaccine hesitancyHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-5-best-practices-addressing-vaccine-hesitancy.html Optimizing communication material to address vaccine hesitancyHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-5-pratiques-exemplaires-face-reticence-vaccination.html Optimizing communication material to address vaccine hesitancyPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05-eng.pdf Optimizing communication material to address vaccine hesitancyPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05f-fra.pdf Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak updateHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-6-id-news.html Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak updateHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-6-actualites-maladies-infectieuses.html Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak updatePDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06-eng.pdf Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak updatePDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06f-fra.pdf

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Data and Resources

Similar records